Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activities
Growth Metrics
Income Statement
Others
Ratios

Selectis Health (GBCS) Cash from Investing Activities (2017 - 2025)

Historic Cash from Investing Activities for Selectis Health (GBCS) over the last 14 years, with Q3 2025 value amounting to -$4233.0.

  • Selectis Health's Cash from Investing Activities fell 76661.42% to -$4233.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$396824.0, marking a year-over-year decrease of 11615.3%. This contributed to the annual value of $2.4 million for FY2024, which is 831585.98% up from last year.
  • According to the latest figures from Q3 2025, Selectis Health's Cash from Investing Activities is -$4233.0, which was down 76661.42% from -$163515.0 recorded in Q2 2025.
  • Over the past 5 years, Selectis Health's Cash from Investing Activities peaked at $2.6 million during Q2 2024, and registered a low of -$239679.0 during Q3 2022.
  • Moreover, its 5-year median value for Cash from Investing Activities was -$34706.5 (2022), whereas its average is $71667.1.
  • As far as peak fluctuations go, Selectis Health's Cash from Investing Activities skyrocketed by 51879.01% in 2022, and later crashed by 76661.42% in 2025.
  • Selectis Health's Cash from Investing Activities (Quarter) stood at -$25886.0 in 2021, then skyrocketed by 518.79% to $108408.0 in 2022, then crashed by 101.77% to -$1914.0 in 2023, then crashed by 413.9% to -$9836.0 in 2024, then surged by 56.96% to -$4233.0 in 2025.
  • Its Cash from Investing Activities stands at -$4233.0 for Q3 2025, versus -$163515.0 for Q2 2025 and -$219240.0 for Q1 2025.